AU1133901A - Method of treating metabolic disorders - Google Patents
Method of treating metabolic disordersInfo
- Publication number
- AU1133901A AU1133901A AU11339/01A AU1133901A AU1133901A AU 1133901 A AU1133901 A AU 1133901A AU 11339/01 A AU11339/01 A AU 11339/01A AU 1133901 A AU1133901 A AU 1133901A AU 1133901 A AU1133901 A AU 1133901A
- Authority
- AU
- Australia
- Prior art keywords
- metabolic disorders
- treating metabolic
- treating
- disorders
- metabolic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41530799A | 1999-10-08 | 1999-10-08 | |
US41530899A | 1999-10-08 | 1999-10-08 | |
US09415307 | 1999-10-08 | ||
US09415308 | 1999-10-08 | ||
PCT/EP2000/009816 WO2001026639A2 (en) | 1999-10-08 | 2000-10-06 | Pharmaceutical composition of ateglinide and another antidiabeticagent |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1133901A true AU1133901A (en) | 2001-04-23 |
Family
ID=27022945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU11339/01A Abandoned AU1133901A (en) | 1999-10-08 | 2000-10-06 | Method of treating metabolic disorders |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1218015A2 (en) |
AU (1) | AU1133901A (en) |
WO (1) | WO2001026639A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001234114A1 (en) * | 2000-02-24 | 2001-09-03 | Takeda Chemical Industries Ltd. | Drugs containing combined active ingredients |
CA2403442A1 (en) * | 2000-03-17 | 2002-09-17 | Ajinomoto Co., Inc. | Use of nateglinide alone or in combination for the treatment or prevention of diabetic complications |
US20040143015A1 (en) * | 2001-03-12 | 2004-07-22 | Villhauer Edwin Bernard | Combination of organic compounds |
AU2002319381A1 (en) * | 2001-06-20 | 2003-01-21 | Merck Sante | Use of antidiabetics for making a medicine with cicatrizing effect |
JP2005519949A (en) * | 2002-03-11 | 2005-07-07 | ノバルティス アクチエンゲゼルシャフト | Nateglinide salt |
DK1547614T3 (en) * | 2002-05-28 | 2011-04-04 | Ajinomoto Kk | Medical composition for inhibiting the expression of ATP citrate lyase and its use |
WO2005092319A1 (en) * | 2004-03-29 | 2005-10-06 | Ranbaxy Laboratories Limited | Rapidly disintegrating pharmaceutical compositions comprising nateglinide and a disintegrant |
CN101756971B (en) * | 2008-10-09 | 2013-09-18 | 北京德众万全药物技术开发有限公司 | Oral solid drug composition of metformin hydrochloride repaglinide |
CN107106583B (en) * | 2015-06-05 | 2021-04-13 | 台中荣民总医院 | Pharmaceutical compositions comprising acarbose and their use for immunomodulation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW438587B (en) * | 1995-06-20 | 2001-06-07 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
-
2000
- 2000-10-06 EP EP00972695A patent/EP1218015A2/en not_active Withdrawn
- 2000-10-06 WO PCT/EP2000/009816 patent/WO2001026639A2/en not_active Application Discontinuation
- 2000-10-06 AU AU11339/01A patent/AU1133901A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001026639A2 (en) | 2001-04-19 |
EP1218015A2 (en) | 2002-07-03 |
WO2001026639A3 (en) | 2002-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001249881A1 (en) | Method of treating the heart | |
AU6578998A (en) | Method of treatment of migraine | |
HU0001471D0 (en) | New method of treatment | |
IL145875A0 (en) | Novel method of treatment | |
AU3977700A (en) | Method of treating neurological disorders | |
AU5042000A (en) | Methods of treating proliferative disorders | |
AU4552200A (en) | Method of treating psychotic disorders | |
AU1133901A (en) | Method of treating metabolic disorders | |
AU3757300A (en) | Method of treating anxiety disorders | |
AU1735800A (en) | Method of treating seizure disorders | |
AU2080201A (en) | Treatment of addiction disorders | |
AU1282099A (en) | Method for treatment of disorders of attention | |
AU3753500A (en) | Methods of treating fibrinogen-related disorders | |
AUPP508798A0 (en) | Method of treating psoriasis | |
AU5861700A (en) | Method of threading | |
AU4598400A (en) | Method of treatment | |
GB9930688D0 (en) | Novel method of treatment | |
AU2002257569A1 (en) | Method of treating metabolic disorders using neuronatin polypeptides | |
AU2382601A (en) | Novel method of treatment | |
AU8031700A (en) | Method of treating fibrosis | |
AU1784701A (en) | Method of treating neuroblastoma | |
AU2001236909A1 (en) | Method of treating disorders of the eye | |
AUPQ320299A0 (en) | Method of treatment | |
AUPQ233299A0 (en) | Method of treatment | |
AUPQ080999A0 (en) | Method of treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |